Related Experiment Video
Updated: Jul 3, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
RNA Sequencing in Disease Diagnosis.
Craig Smail1, Stephen B Montgomery2
1Genomic Medicine Center, Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri, USA;
Annual Review of Genomics and Human Genetics
|February 15, 2024
Summary
RNA sequencing (RNA-seq) is a powerful tool for understanding disease by measuring gene activity. New technologies and large datasets are improving its use in diagnosing diseases and finding genetic causes.
Area of Science:
- Genomics and Molecular Biology
- Bioinformatics and Computational Biology
Background:
- RNA sequencing (RNA-seq) is crucial for transcriptomic phenotype measurement and modeling disease variant impacts.
- Technological advancements enhance RNA-seq applications for biomarker discovery, tissue-specific effects, and disease mechanism localization.
Purpose of the Study:
- To highlight the expanding utility of RNA sequencing (RNA-seq) in disease research.
- To emphasize the role of large-scale transcriptomic data and advanced analysis in disease diagnosis.
Main Methods:
- Utilizing advances in RNA sequencing technologies, experimental protocols, and analysis strategies.
- Leveraging biobank-scale transcriptomic repositories with matched genomic data.
- Employing improved computational analysis pipelines for phenotype detection.
Main Results:
- RNA-seq effectively identifies disease biomarkers and tissue/cell-type-specific impacts.
- Large-scale transcriptomic resources facilitate the detection of aberrant phenotypes in rare diseases.
- Improved analysis pipelines enhance the resolution of disease origins and causal gene contributions.
Conclusions:
- RNA sequencing is increasingly vital for disease diagnosis and understanding disease mechanisms.
- The integration of large-scale transcriptomic and genomic data offers unprecedented insights into disease.
- Continued expansion of transcriptomic resources will further advance biomedical research and diagnostics.
Related Concept Videos
RNA-seq
10.0K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.0K
Sanger Sequencing
754.3K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
754.3K
Next-generation Sequencing
88.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.8K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K

